Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: J Gastroenterol Hepatol. 2016 Jan;31(1):133–137. doi: 10.1111/jgh.13176

Table 1.

Comparison between CD patients, GI controls and Healthy controls

Total GI controlsa (Group 2) P value CDb vs GI controls CD (Group 1) P value CD vs Healthy controls Healthy Controls (Group 3)
Total 1000 446 - 315 - 239
Mean Age (years) 43.7 (18 – 93) 44.1 (18 – 89) .6515 44.6 (18 – 92) .0249* 41.7 (18–93)
Females 662 (66.20%) 298 (66.82%) .078 230 (73%) <.0001* 134 (56.07%)
SIgADc n (%) 10 (1%) 3 (0.67%) .173 6 (1.90%) .248 1 (0.42%)
PIgADd n (%) 61 (6.10%) 32 (7.17%) .22 15 (4.76%) .57 14 (5.86%)
Mean IgA (mg/Dl) 202 (0 – 800) 201 (0 – 800) .12 215 (0 – 800) .0030* 185 (0 – 800)
a

Non Celiac Disease patients with gastrointestinal symptoms,

b

Celiac Disease,

c

Selective immunoglobulin A deficiency,

d

Partial Immunoglobulin A deficiency,

*

Significant P value